Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection
  • Published Date:

    6/21/18

  • Language:
    English
Filetype[PDF-155.65 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 511.83 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.)
    Published Date:
    12/12/13
    Description:
    Proteja a su familia y amigos de la tuberculosis: ¡tómese todos sus medicamentos para la tuberculosis!CS244103-BPublications date for document properties.
    File Type:
    Filetype[PDF - 511.83 KB]
  2. Filetype[PDF - 150.71 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.)
    Published Date:
    6/28/18
    Description:
    To treat your latent TB infection, take two medicines (rifapentine and isoniazid) once a week, for 12 weeks. It is important to take all of your medication. If you miss taking your pills for the week, call your doctor/clinic right away.CS292653Awww.c...
    File Type:
    Filetype[PDF - 150.71 KB]
  3. Filetype[PDF - 507.25 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    10/9/12
    File Type:
    Filetype[PDF - 507.25 KB]
  4. Filetype[PDF - 84.80 KB]
    Personal Author:
    Olano-Soler, Henry; Thomas, Dana; Joglar, Olga; Rios, Katrina; Torres-Rodríguez, Milton; Duran-Guzman, Greduvel; Chorba, Terence;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office for State, Tribal, Local and Territorial Support. Public Health Associate Program.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Divisoin of Tuberculosis Elimination.. Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of State and Local Readiness..
    Published Date:
    Dec 22 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(50):1386-1387.
    File Type:
    Filetype[PDF - 84.80 KB]
  5. Filetype[PDF - 195.72 KB]
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    November 2011
    Source:
    TB elimination
    Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. Certain groups are at very high risk ...
    File Type:
    Filetype[PDF - 195.72 KB]